Dunhill Financial’s GoodRx Holdings GDRX Stock Holding History

Dunhill Financial’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$5	–	1736
2026 Q1	$5	Sell	2 -1	-33%	-$2	﹤0.01%	1846
2025 Q4	$7	Buy	+3	New	+$10	﹤0.01%	1998

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dunhill Financial's GDRX Position: Q2 2026 in Review

Dunhill Financial sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 2 shares — an estimated $5 sold.

Dunhill Financial first reported a position in GDRX in Q4 2025 and held it in 2 quarters. The position peaked at $7 in Q4 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Dunhill Financial reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
Dunhill Financial sold 2 GoodRx Holdings shares in Q2 2026, an estimated $5.
Dunhill Financial first reported a position in GoodRx Holdings in Q4 2025 and held it in 2 quarters.
Dunhill Financial's GoodRx Holdings position peaked at $7 in Q4 2025.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.